These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 19917478)

  • 1. Mesonephric remnant hyperplasia: an unusual benign mimicker of prostate cancer.
    Yacoub M; Milin S; Irani J; Fromont G
    Ann Diagn Pathol; 2009 Dec; 13(6):402-4. PubMed ID: 19917478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesonephric remnants of the prostate: incidence and histologic spectrum.
    Bostwick DG; Qian J; Ma J; Muir TE
    Mod Pathol; 2003 Jul; 16(7):630-5. PubMed ID: 12861057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of pluripotency marker Oct 3/4 in prostate cancer and benign prostate hyperplasia.
    Monsef N; Soller M; Isaksson M; Abrahamsson PA; Panagopoulos I
    Prostate; 2009 Jun; 69(9):909-16. PubMed ID: 19274762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer.
    Ummanni R; Junker H; Zimmermann U; Venz S; Teller S; Giebel J; Scharf C; Woenckhaus C; Dombrowski F; Walther R
    Cancer Lett; 2008 Aug; 266(2):171-85. PubMed ID: 18384941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of a novel biomarker, alphas1-Casein, a milk protein, in benign prostate hyperplasia.
    Xu K; Ling MT; Wang X; Wong YC
    Prostate Cancer Prostatic Dis; 2006; 9(3):293-7. PubMed ID: 16683014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesonephric remnant hyperplasia involving prostate and periprostatic tissue: findings at radical prostatectomy.
    Chen YB; Fine SW; Epstein JI
    Am J Surg Pathol; 2011 Jul; 35(7):1054-61. PubMed ID: 21606823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological aspects of prostate cancer and benign nodular hyperplasia.
    Wernert N; Bieroff E; Hügel A
    Anticancer Res; 1997; 17(4B):2907-10. PubMed ID: 9329560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applications of immunohistochemistry to the diagnosis and prognostication of prostate carcinoma and prostatic intraepithelial neoplasia.
    Maygarden SJ
    Pathol Annu; 1994; 29 Pt 1():303-20. PubMed ID: 7510385
    [No Abstract]   [Full Text] [Related]  

  • 9. [Various immunohistochemical markers of precancer and variants of prostate cancer].
    Romanenko AM; Vorob'eva LR
    Arkh Patol; 1995; 57(4):38-41. PubMed ID: 8526754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tumor infiltrating dendritic cells and Mucin1 gene expression in benign prostatic hyperplasia and prostate cancer].
    Xiang ST; Zhou SW; Guan W; Wang QZ; Zhang B; Liu JH; Ye ZQ
    Zhonghua Nan Ke Xue; 2003 Oct; 9(7):497-500. PubMed ID: 14628595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early prostate cancer antigen expression in predicting presence of prostate cancer in men with histologically negative biopsies.
    Hansel DE; DeMarzo AM; Platz EA; Jadallah S; Hicks J; Epstein JI; Partin AW; Netto GJ
    J Urol; 2007 May; 177(5):1736-40. PubMed ID: 17437801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical sclerosing adenosis of the prostate: a rare mimic of adenocarcinoma.
    Cheng L; Bostwick DG
    Histopathology; 2010 Apr; 56(5):627-31. PubMed ID: 20459573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of serum-free and total prostate-specific antigen due to prostatic intraepithelial neoplasia.
    Minardi D; Galosi AB; Dell'Atti L; Hanitzsch H; Mario P; Muzzonigro G
    Scand J Urol Nephrol; 2002; 36(5):323-9. PubMed ID: 12487735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phyllodes tumor of the prostate: a case report.
    Ito H; Ito M; Mitsuhata N; Tahara E
    Jpn J Clin Oncol; 1989 Sep; 19(3):299-304. PubMed ID: 2478740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical expression of prostatic antigens in adenocarcinoma and villous adenoma of the urinary bladder.
    Lane Z; Hansel DE; Epstein JI
    Am J Surg Pathol; 2008 Sep; 32(9):1322-6. PubMed ID: 18670358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
    Zhao Z; Liu J; Li S; Shen W
    Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperplasia of prostatic mesonephric remnants: a potential pitfall in the evaluation of prostate gland biopsy.
    Val-Bernal JF; Gómez-Ortega JM
    J Urol; 1995 Sep; 154(3):1138-9. PubMed ID: 7543609
    [No Abstract]   [Full Text] [Related]  

  • 18. A theoretical rationale on the histogenesis of premalignant lesions and early carcinoma of the prostate.
    Botticelli AR
    Pathologica; 1994 Apr; 86(2):128-41. PubMed ID: 7524011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoreactivity of ubiquitin in human prostate gland.
    Bataineh ZM; Habbal O
    Neuro Endocrinol Lett; 2006 Aug; 27(4):517-22. PubMed ID: 16892003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of cyclooxygenase-2 and vascular endothelial growth factor in human prostate cancer and its significance].
    Jin TX; Li XG; Wu WY; Piao DM; Feng JY; Sang J
    Zhonghua Nan Ke Xue; 2006 Mar; 12(3):207-10. PubMed ID: 16597032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.